Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.
CLINICAL INFECTIOUS DISEASES(2011)
摘要
The impact of cotrimoxazole (CTX) on growth and/or anemia was investigated in 541 human immunodeficiency virus-infected, antiretroviral therapy-naive Zambian children enrolled in the Children with HIV Antibiotic Prophylaxis trial. Compared with children randomized to receive placebo, children randomized to receive CTX had slower decreases in weight-for-age (P = .04) and height-for-age (P = .01), and greater increase in hemoglobin level (P = .01). These findings argue for expanded early CTX use.
更多查看译文
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要